Prostate cancer: Relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis

Radiology

Volumn 248, Issue 2, 2008, Pages 531-539

  Tamada, Tsutomu ^a   Sone, Teruki ^a   Jo, Yoshimasa ^a   Yamamoto, Akira ^a   Yamashita, Takenori ^a   Egashira, Naoto ^a   Imai, Shigeki ^a   Fukunaga, Masao ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; CONTRAST MEDIUM;

ARTICLE; BLEEDING; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; AGED; BIOPSY; ENDOSCOPIC ECHOGRAPHY; MALE; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; PREDICTION AND FORECASTING; PROSTATE TUMOR; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; BIOPSY; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 49049118078     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2482070157     Document Type: Article

References (38)

1. Thornbury JR, Ornstein DK, Choyke PL, Langlotz CP, Weinreb JC. Prostate cancer: what is the future role for imaging? AJR Am J Roentgenol 2001;176(1):17-22.
2. Yu KK, Hricak H. Imaging prostate cancer. Radiol Clin North Am 2000;38(1):59-85.
3. White S, Hricak H, Forstner R, et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 1995;195(2):385-390.
4. Schiebler ML, Schnall MD, Pollack HM, et al. Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology 1993;189(2):339-352.
5. Schiebler ML, Tomaszewski JE, Bezzi M, et al. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high resolution MR and histopathologic findings. Radiology 1989;172(1):131-137.
6. Sommer FG, Nghiem HV, Herfkens R, McNeab J, Low RN. Determining the volume of prostatic carcinoma: value of MR imaging with an external-array coil. AJR Am J Roentgenol 1993;161(1):81-86.
7. Ramchandani P, Schnall MD. Magnetic resonance imaging of the prostate. Semin Roentgenol 1993;28(1):74-82.
8. Ikonen S, Kivisaari L, Vehmas T, et al. Optimal timing of post-biopsy MR imaging of the prostate. Acta Radiol 2001;42(1):70-73.
9. Qayyum A, Coakley FV, Yu Y, et al. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol 2004;183(4):1079-1083.
10. Kaji Y, Kurhanewicz J, Hricak H, et al. Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging. Radiology 1998;206(3):785-790.
11. Shimofusa R, Fujimoto H, Akamata H, et al. Diffusion-weighted imaging of prostate cancer. J Comput Assist Tomogr 2005;29(2):149-153.
12. Hosseinzadeh K, Schwarz SD. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging 2004;20(4):654-661.
13. Issa B. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging 2002;16(2):196-200.
14. Song SK, Qu Z, Garabedian EM, Gordon JI, Milbrandt J, Ackerman JJ. Improved magnetic resonance imaging detection of prostate cancer in a transgenic mouse model. Cancer Res 2002;62(5):1555-1558.
15. Gibbs P, Tozer DJ, Liney GP, Turnbull LW. Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate. Magn Reson Med 2001;46(6):1054-1058.
16. Sato C, Naganawa S, Nakamura T, et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 2005;21(3):258-262.
17. Kozlowski P, Chang SD, Jones EC, Berean KW, Chen H, Goldenberg SL. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis: correlation with biopsy and histopathology. J Magn Reson Imaging 2006;24(1):108-113.
18. Kumar V, Jagannathan NR, Kumar R, et al. Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level. Magn Reson Imaging 2006;24(5):541-548.
19. Pickles MD, Gibbs P, Sreenivas M, Turnbull LW. Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T. J Magn Reson Imaging 2006;23(2):130-134.
20. Gibbs P, Pickles MD, Turnbull LW. Diffusion imaging of the prostate at 3.0 tesla. Invest Radiol 2006;41(2):185-188.
21. Takenaka A, Hara R, Hyodo Y, et al. Transperineal extended biopsy improves the clinically significant prostate cancer detection rate: a comparative study of 6 and 12 biopsy cores. Int J Urol 2006;13(1):10-14.
22. Akin O, Sala E, Moskowitz CS, et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 2006;239(3):784-792.
23. Tamada T, Sone T, Nagai K, et al. T2-weighted MR imaging of prostate cancer: multishot echo-planar imaging vs fast spinecho imaging. Eur Radiol 2004;14(2):318-325.
24. Ryan TA. Significance tests for multiple comparison of proportions, variances, and other statistics. Psychol Bull 1960;57(4):318-328.
25. Janssen MJ, Huijgens PC, Bouman AA, Oe PL, Donker AJ, van der Meulen J. Citrate versus heparin anticoagulation in chronic haemodialysis patients. Nephrol Dial Transplant 1993;8(11):1228-1233.
26. Bauer JJ, Zeng J, Zhang W, et al. Lateral biopsies added to the traditional sextant prostate biopsy pattern increases the detection rate of prostate cancer. Prostate Cancer Prostatic Dis 2000;3(1):43-46.
27. Reinsberg SA, Payne GS, Riches SF, et al. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. AJR Am J Roentgenol 2007;188(1):91-98.
28. Scheenen TW, Weiland E, Fütterer JJ, et al. Preliminary results of IMAPS: an international multi-centre assessment of prostate MR spectroscopy [abstr]. Proceedings of the 13th meeting of the International Society for Magnetic Resonance in Medicine, Berkeley, Calif, May 7-13, 2005.
29. Silvera S, Oppenheim C, Touze E, et al. Spontaneous intracerebral hematoma on diffusion-weighted images: influence of T2-shine-through and T2-blackout effects. AJNR Am J Neuroradiol 2005;26(2):236-241.
30. Lin DD, Filippi CG, Steever AB, Zimmerman RD. Detection of intracranial hemorrhage: comparison between gradient-echo images and b(0) images obtained from diffusion-weighted echo-planar sequences. AJNR Am J Neuroradiol 2001;22(7):1275-1281.
31. Padhani AR, Gapinski CJ, Macvicar DA, et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumor stage, histological grade and PSA. Clin Radiol 2000;55(2):99-109.
32. Muramoto S, Uematsu H, Kimura H, et al. Differentiation of prostate cancer from benign prostate hypertrophy using dual-echo dynamic contrast MR imaging. Eur J Radiol 2002;44(1):52-58.
33. Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986;161(2):401-407.
34. Le Bihan D. Molecular diffusion nuclear magnetic resonance imaging. Magn Reson Q 1991;7(1):1-30.
35. Lyng H, Haraldseth O, Rofstad EK. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging. Magn Reson Med 2000;43(6):828-836.
36. Anderson AW, Xie J, Pizzonia J, Bronen RA, Spencer DD, Gore JC. Effects of cell volume fraction changes on apparent diffusion in human cells. Magn Reson Imaging 2000;18(6):689-695.
37. Stamey TA, Yemoto CE. The clinical importance of separating transition zone (TZ) from peripheral zone (PZ) cancers [abstr]. J Urol 1998;159(2S):221.
38. Wefer AE, Hricak H, Vigneron DB, et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 2000;164(2):400-404.